Comments

DiaMedica Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

DMACNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.51

-0.19-5.14%

At close: -

$3.77

0.267.41%

After Hours: Apr 9, 4:18 PM EDT

DiaMedica Therapeutics (DMAC) Forecast

News Earnings DiaMedica Therapeutics (DMAC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

DiaMedica Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DMAC | Benzinga

Explore DiaMedica Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DMAC.

Open	$3.64
Close	$3.51
Volume / Avg.	58.48K / 90.11K
Day Range	$3.40 - $3.82
52 Wk Range	2.14 - 6.82
Market Cap	$161.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	1.24%
Days to Cover	3.4

Recent News

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a

Nabaparna Bhattacharya

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.64
Close	$3.51
Volume / Avg.	58.48K / 90.11K
Day Range	$3.40 - $3.82
52 Wk Range	2.14 - 6.82
Market Cap	$161.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	1.24%
Days to Cover	3.4

About

Sector

Healthcare

Industry

N/A

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in ...

Got Questions? Ask

How is DMAC's price-to-book ratio?

How is DMAC's revenue growing?

What are analysts' targets for DMAC?

What is DMAC's all-time low price?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DiaMedica Therapeutics (DMAC) stock?

You can purchase shares of DiaMedica Therapeutics (NASDAQ:DMAC) through any online brokerage.

View our list of the best stock brokerages

Who are DiaMedica Therapeutics (DMAC) competitors?

There are no as such competitors for DiaMedica Therapeutics.

What is the forecast, or price target, for DiaMedica Therapeutics (DMAC) stock?

DiaMedica Therapeutics has a consensus price target of $8.00.

What is the current price for DiaMedica Therapeutics (DMAC)?

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $3.77 last updated April 9, 2025 at 4:18 PM EDT.

Does DiaMedica Therapeutics (DMAC) pay a dividend?

There are no upcoming dividends for DiaMedica Therapeutics.

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

DiaMedica Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is DiaMedica Therapeutics (DMAC) going to split?

There is no upcoming split for DiaMedica Therapeutics.

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.